Healthkick Podcast

Healthkick Podcast

Podcasts

Tim is Stockhead’s resident Health and Biotech expert with his weekly column “Dr Boreham’s Crucible”. Tim was the author of the Criterion column in The Australian newspaper for well over 10 years and has more than three decades’ experience of business reporting across three major publications.

Health & Biotech

Health Kick Podcast: Coronavirus, HIV and hepatitis are in the sights of Aussie biotech Biotron

February 12, 2020February 12, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: Novel gene targeting therapies, protein disruptors and why ANP’s recent trial success have investors buzzing

February 5, 2020February 6, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles

January 30, 2020January 30, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: Commercialising orphan drugs, the need for better regulation and the ASX’s lifestyle play problem

December 18, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: The science behind 2019’s hottest IPO and the company’s plans for 2020

December 11, 2019February 12, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: Investing in repurposed drugs, combating intracranial pressure and why Invex caught NASA’s eye

December 4, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?

November 27, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: Developing drugs, fighting fibrosis and squeezing squishometers

November 20, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: How Aussie health stocks are performing internationally and Prescient’s cancer-blocking innovation

November 13, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: The growth of musculoskeletal disorders, new markets created by ageing populations and OCC’s Avatar moment

November 6, 2019January 24, 2020 | Tim Boreham

Health & Biotech

Health Kick Podcast: The future of X-ray, a new way to image the body and challenging clinical practice

October 30, 2019January 24, 2020 | Tim Boreham

Health & Biotech

The Health Kick Podcast: The death of the doctor’s clipboard and how Alcidion’s infomatics saves lives

October 24, 2019January 24, 2020 | Tim Boreham

Check out Stockhead’s latest HealthKick Podcasts:

Health Kick Podcast: Coronavirus, HIV and hepatitis are in the sights of Aussie biotech Biotron

Health Kick Podcast: Novel gene targeting therapies, protein disruptors and why ANP’s recent trial success have investors buzzing

Health Kick Podcast: Learning from the Swine flu pandemic, the market potential of exosome therapeutics and jumping ASX life-sciences hurdles

Health Kick Podcast: Commercialising orphan drugs, the need for better regulation and the ASX’s lifestyle play problem

Health Kick Podcast: The science behind 2019’s hottest IPO and the company’s plans for 2020

Health Kick Podcast: Investing in repurposed drugs, combating intracranial pressure and why Invex caught NASA’s eye

Health Kick Podcast: What’s holding back better breast cancer detection? And how is Volpara’s tech changing the game?

Health Kick Podcast: Developing drugs, fighting fibrosis and squeezing squishometers

Health Kick Podcast: How Aussie health stocks are performing internationally and Prescient’s cancer-blocking innovation

Health Kick Podcast: The growth of musculoskeletal disorders, new markets created by ageing populations and OCC’s Avatar moment

Health Kick Podcast: The future of X-ray, a new way to image the body and challenging clinical practice

The Health Kick Podcast: The death of the doctor’s clipboard and how Alcidion’s infomatics saves lives

The Health Kick Podcast with Tim Boreham: Anatara Lifesciences

The Health Kick Podcast with Tim Boreham: Kazia Therapeutics

The Health Kick Podcast with Tim Boreham: BioScience Managers

The Health Kick Podcast with Tim Boreham: Oventus Medical

Most Popular

Editor's Picks

The 7 Top Gold Stocks Analysts Tip To Take Off

Thanks for subscribing. Check your email for the link to our exclusive report 'Gold price surge: The 7 top gold stocks analysts say are ready for take-off'.

Don't be the last to know

Most Popular

Editor's Picks

The 7 Top Gold Stocks Analysts Tip To Take Off

Thanks for subscribing. Check your email for the link to our exclusive report 'Gold price surge: The 7 top gold stocks analysts say are ready for take-off'.

Get the latest Stockhead news delivered free to your inbox

I want the news: